000 01403 a2200385 4500
005 20250516133056.0
264 0 _c20130918
008 201309s 0 0 eng d
022 _a1573-904X
024 7 _a10.1007/s11095-013-0979-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKalezic, Ivana
245 0 0 _aIn vivo and ex vivo inhibition of spinal nerve ligation-induced ectopic activity by sodium channel blockers correlate to in vitro inhibition of NaV1.7 and clinical efficacy: a pharmacokinetic-pharmacodynamic translational approach.
_h[electronic resource]
260 _bPharmaceutical research
_cMay 2013
300 _a1409-22 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aHEK293 Cells
650 0 4 _aHumans
650 0 4 _aLigation
650 0 4 _aMale
650 0 4 _aNAV1.7 Voltage-Gated Sodium Channel
_xmetabolism
650 0 4 _aNeuralgia
_xdrug therapy
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSodium Channel Blockers
_xblood
650 0 4 _aSpinal Nerves
_xdrug effects
700 1 _aLuo, Lei
700 1 _aLund, Per-Eric
700 1 _aEriksson, Anders B
700 1 _aBueters, Tjerk
700 1 _aVisser, Sandra A G
773 0 _tPharmaceutical research
_gvol. 30
_gno. 5
_gp. 1409-22
856 4 0 _uhttps://doi.org/10.1007/s11095-013-0979-6
_zAvailable from publisher's website
999 _c22468169
_d22468169